Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. (NMRA) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 98 transactions totaling $135.9M, demonstrating a bullish sentiment with $131.2M in net insider flow. The most recent transaction on Jan 8, 2026 involved a transaction of 750,000 shares valued at $0.
NMRA Insider Activity Summary
Who Is Buying NMRA Stock?
No significant insider buying has been recorded for NMRA in the recent period.
Who Is Selling NMRA Stock?
No significant insider selling has been recorded for NMRA in the recent period.
Is Neumora Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for NMRA is bullish with an Insider Alignment Score of 98/100 and a net flow of $131.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
NMRA Frequently Asked Questions
Understanding NMRA Insider Activity
Insider trading at Neumora Therapeutics, Inc. (NMRA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading NMRA stock, having executed 98 transactions in the past 90 days. The most active insider is Kristina Burow (Executive), who has made 30 transactions totaling $36.4M.
Related Tools
Track Neumora Therapeutics, Inc. Insider Activity
Get notified when executives and directors at NMRA file new Form 4 transactions